Lee011: Clinical Trials

2 trials of Lee011, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Active not recruiting 1, Recruiting 1

Follow Lee011: new trials by email Literature Review of Lee011 trials Research Report on Lee011

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Roll-over Study to Allow Continued Access to Ribociclib
Ribociclib, Letrozole, Anastrozole - Metastatic Breast Cancer
Phase 4Active not recruitingNovartis Pharmaceuticals1342022-07-072026-10-19
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
Binimetinib, Encorafenib, Vemurafenib - Solid Tumors
Phase 4RecruitingPfizer2102022-07-052026-10-19

Conditions studied

Breast Neoplasms (1)

Sponsors

Novartis Pharmaceuticals (1)  ·  Pfizer (1)

Countries

Brazil (2)  ·  Greece (2)  ·  Italy (2)  ·  Portugal (2)  ·  South Korea (2)  ·  Spain (2)  ·  Turkey (Türkiye) (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Canada (1)  ·  China (1)  ·  Costa Rica (1)  ·  Czechia (1)  ·  France (1)

NIH funding

2023 (1)